Home West Coast South San Francisco, CA Septerna COMPANY
Clinical Phase 1
7 open jobs · last seen Oct 23, 2026 · 4 sources
Location: South San Francisco, CA · source · Oct 14, 2026
Profile checked Oct 10, 2026
Keywords: SEP-479 SEP-631
Hiring Title Location (from posting) Employer posted First seen Director/Senior Director, AI/ML for Drug Discovery South San Francisco, California, United States Oct 15, 2026 Oct 16, 2026 Director, Program and Portfolio Management South San Francisco, California, United States Oct 8, 2026 Oct 11, 2026 Senior Medical Director, Clinical Development South San Francisco, California, United States Oct 7, 2026 Oct 11, 2026 Scientist/Research Scientist, Molecular Pharmacology (contract position) South San Francisco, California, United States Oct 6, 2026 Oct 11, 2026 Staff/ Senior Staff Scientist, DMPK South San Francisco, California, United States Sep 17, 2026 Oct 11, 2026
See all 7 jobs
At a glance HQ South San Francisco, CA source Region West Coast Stage Clinical Phase 1 Latest trial Phase 1: A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants (Mar 4, 2026) source Timeline Mar 4, 2026 Trial start Phase 1: A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants source ↗ Jul 15, 2025 Trial start Phase 1: A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers source ↗ May 14, 2025 Partnership Partnership / licensing: $200M (upfront, as published), announced May 14, 2025. Source: SEC filing. source ↗ Oct 30, 2024 Raise IPO: $331.2M (total, as published), announced Oct 30, 2024. Source: company release on GlobeNewswire. source ↗ Upcoming milestones 2027-02 (ESTIMATED) · Phase 1 · A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants · NCT07433179 Estimated primary completion per ClinicalTrials.gov. Dates move.
Funding Raised: $331.2M. Last 2 years.
Oct 30, 2024 IPO: $331.2M (total, as published), announced Oct 30, 2024. Source: company release on GlobeNewswire. source ↗ May 14, 2025 Partnership / licensing: $200M (upfront, as published), announced May 14, 2025. Source: SEC filing. source ↗ Clinical trials (lead sponsor) 2 Record Title Phase Status Start Primary completion NCT07433179 A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants Phase 1 Recruiting Mar 4, 2026 2027-02 (estimated) NCT07069036 A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers Phase 1 Completed Jul 15, 2025 Dec 18, 2025 (actual)
Open jobs 7 Title Location (from posting, not HQ) Employer posted First seen Level Director/Senior Director, AI/ML for Drug Discovery South San Francisco, California, United States Oct 15, 2026 Oct 16, 2026 Not stated Director, Program and Portfolio Management South San Francisco, California, United States Oct 8, 2026 Oct 11, 2026 Senior Description Senior Medical Director, Clinical Development South San Francisco, California, United States Oct 7, 2026 Oct 11, 2026 Senior Description Scientist/Research Scientist, Molecular Pharmacology (contract position) South San Francisco, California, United States Oct 6, 2026 Oct 11, 2026 Senior Description Staff/ Senior Staff Scientist, DMPK South San Francisco, California, United States Sep 17, 2026 Oct 11, 2026 Senior Description Senior Director, Regulatory Affairs South San Francisco, California, United States Sep 14, 2026 Oct 11, 2026 Senior Description Associate Director, Process Chemistry South San Francisco, California, United States Aug 11, 2026 Oct 11, 2026 Senior Description
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
